{"id":710419,"date":"2024-08-19T17:44:01","date_gmt":"2024-08-19T17:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=710419"},"modified":"2024-08-19T17:44:01","modified_gmt":"2024-08-19T17:44:01","slug":"microtome-market-worth-585-million-by-2027-exclusive-report-by-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/microtome-market-worth-585-million-by-2027-exclusive-report-by-marketsandmarkets_710419.html","title":{"rendered":"Microtome Market worth $585 million by 2027 &#8211; Exclusive Report by MarketsandMarkets\u2122"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1724067218.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Microtome Market worth $585 million by 2027 - Exclusive Report by MarketsandMarkets&trade;\" src=\"https:\/\/www.abnewswire.com\/uploads\/1724067218.jpeg\" alt=\"Microtome Market worth $585 million by 2027 - Exclusive Report by MarketsandMarkets&trade;\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>North America region, the microtome market is devided into US and cananda. US is expected to dominate the market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is the key factor driving market growth in the US.<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The growth of this market is majorly driven by rising prevalence of cancer, growing demand for digital pathology, recommendations for cancer screening, availability of reimbursement<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/microtomes-market-230495411.html?utm_source=abnewswire&amp;utm_medium=referral&amp;utm_campaign=microtomemarket\"  target=\"_blank\">Microtome Market<\/a><strong>&nbsp;by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) &#8211; Global Forecast to 2027&#8243;,<\/strong>&nbsp;published by MarketsandMarkets&trade;, the global market is expected to reach&nbsp;USD 585 million&nbsp;by 2027 from&nbsp;USD 425 million&nbsp;in 2022, at a CAGR of 6.6% during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=230495411&amp;utm_source=abnewswire&amp;utm_medium=referral&amp;utm_campaign=microtomemarket\"  target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=230495411<\/a><\/p>\n<p style=\"text-align: justify;\">The growth of this market is majorly driven by rising prevalence of cancer, growing demand for digital pathology, recommendations for cancer screening, availability of reimbursement. However, Lack of skilled professionals, and availability of refurbished products are some of the challenges for which may hinder the growth of this market.<\/p>\n<p style=\"text-align: justify;\"><strong>Microtome instruments in the product segment to witness the highest shares during the forecast period.&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated market.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=230495411&amp;utm_source=abnewswire&amp;utm_medium=referral&amp;utm_campaign=microtomemarket\"  target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=230495411<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>US dominates the North American microtome market<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on the&nbsp;North America&nbsp;region, the microtome market is devided into US and cananda. US is expected to dominate the market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is the key factor driving market growth in the US.<\/p>\n<p style=\"text-align: justify;\">The major players in the microtome market are Danaher Corporation (US), PHC holdings corporation (Japan), Cardinal Health (US), Boeckeler Instruments, Inc (US), SM Scientific Instruments Pvt. Ltd. (India), Bright Instruments (UK), Sakura Finetek&nbsp;USA, Inc (US), Jinhua Yidi Medical Equipment Co., Ltd (China),&nbsp;Ted Pella, Inc (US), Medimeas (India), SLEE medical GmbH (Germany), Histo-Line Laboratories (Italy), microTec Laborger&auml;te GmbH (Germany), MEDITE Medical GmbH (Germany), Erma Inc. (Japan)<\/p>\n<p style=\"text-align: justify;\"><strong>Speak to Analyst:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/speaktoanalystNew.asp?id=230495411&amp;utm_source=abnewswire&amp;utm_medium=referral&amp;utm_campaign=microtomemarket\"  target=\"_blank\">https:\/\/www.marketsandmarkets.com\/speaktoanalystNew.asp?id=230495411<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/prnewswire.com_17712.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=microtome-market-worth-585-million-by-2027-exclusive-report-by-marketsandmarkets\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.prnewswire.com\/news-releases\/microtome-market-worth-585-million-by-2027--exclusive-report-by-marketsandmarkets-301542393.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.prnewswire.com\/news-releases\/microtome-market-worth-585-million-by-2027&#8211;exclusive-report-by-marketsandmarkets-301542393.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.prnewswire.com\/news-releases\/microtome-market-worth-585-million-by-2027--exclusive-report-by-marketsandmarkets-301542393.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=microtome-market-worth-585-million-by-2027-exclusive-report-by-marketsandmarkets\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>North America region, the microtome market is devided into US and cananda. US is expected to dominate the market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/microtome-market-worth-585-million-by-2027-exclusive-report-by-marketsandmarkets_710419.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-710419","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/710419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=710419"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/710419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=710419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=710419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=710419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}